Disc Medicine Inc. (IRON)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.64B
Last updated: Nov 17, 2026 at 11:06 AM ET
Disc Medicine Inc. (IRON) Competitors
The companies most similar to Disc Medicine are Legend Biotech (LEGN), Dyne Therapeutics (DYN) and MBX Biosciences, Inc. Common Stock (MBX). By market cap, Disc Medicine ranks 4th of the 13 companies on this page; Scholar Rock Holding (SRRK) is the largest at $5.27B.
Peer Comparison
IRON's ROIC of -40.0% is above the peer median of -41.8%, and its revenue growth of 0.0% is above the median of -31.8%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Disc Medicine (IRON) | $3.64B | N/A | N/A | 0.0% | -40.0% | 0.0% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Dyne Therapeutics Inc (DYN) | $3.22B | N/A | N/A | 0.0% | -42.9% | 0.0% | 0.00% |
| MBX Biosciences, Inc. Common Stock (MBX) | $2.78B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Celldex Therapeutics Inc (CLDX) | $2.26B | N/A | N/A | 0.0% | N/A | -97.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Denali Therapeutics Inc (DNLI) | $3.00B | N/A | 159.3x | 0.0% | N/A | -100.0% | 0.00% |
| Dianthus Therapeutics Inc. (DNTH) | $5.17B | N/A | N/A | 0.0% | N/A | 205.6% | 0.00% |
| Celcuity LLC (CELC) | $3.15B | N/A | N/A | 0.0% | -25.2% | 0.0% | 0.00% |
| Xencor Inc (XNCR) | $2.78B | N/A | 13.5x | -58.8% | -17.3% | 454.9% | 0.00% |
| Cogent Biosciences Inc (COGT) | $4.97B | N/A | N/A | 0.0% | -43.4% | -100.0% | 0.00% |
| Scholar Rock Holding Corp (SRRK) | $5.27B | N/A | N/A | 0.0% | -89.0% | -100.0% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Peer median | $3.18B | 266.5x | 15.0x | 0.0% | -41.8% | -31.8% | 0.00% |
Similar Companies
These are the 12 companies most similar to Disc Medicine, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Dyne Therapeutics Inc (DYN) | Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases... | DYN competitors |
| MBX Biosciences, Inc. Common Stock (MBX) | MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment... | MBX competitors |
| Celldex Therapeutics Inc (CLDX) | Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment... | CLDX competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Denali Therapeutics Inc (DNLI) | Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. | DNLI competitors |
| Dianthus Therapeutics Inc. (DNTH) | Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops... | DNTH competitors |
| Celcuity LLC (CELC) | Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States. | CELC competitors |
| Xencor Inc (XNCR) | Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed... | XNCR competitors |
| Cogent Biosciences Inc (COGT) | Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. | COGT competitors |
| Scholar Rock Holding Corp (SRRK) | Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious... | SRRK competitors |
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
Frequently Asked Questions About IRON
Who are Disc Medicine's main competitors?
The companies most similar to Disc Medicine include Legend Biotech (LEGN), Dyne Therapeutics (DYN), MBX Biosciences, Inc. Common Stock (MBX), Celldex Therapeutics (CLDX) and Beam Therapeutics (BEAM), listed from the closest match.
Who is Disc Medicine's biggest competitor?
Scholar Rock Holding (SRRK) is the largest of the similar companies at $5.27B; Legend Biotech (LEGN) is the closest match by business profile, size, sector and industry.
How does IRON stock compare with its competitors?
IRON's net margin is 0.0% against a peer median of 0.0%.
Which of Disc Medicine's competitors pays a higher dividend?
Disc Medicine pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Disc Medicine bigger than its competitors?
No. Disc Medicine is 4th by market cap among the 13 companies on this page; the largest is Scholar Rock Holding (SRRK) at $5.27B.
IRON pages: Overview, Earnings, Forecast, Financials, Competitors